BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 32666771)

  • 1. Ocular Hypertension, Glaucoma or Compressive Neuropathy in Patient with Active TED.
    Stoyanova NS; Konareva-Kostianeva MI; Mitkova-Hristova VT
    Folia Med (Plovdiv); 2020 Jun; 62(2):418-423. PubMed ID: 32666771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ocular hypertension and optic neuropathies secondary to dysthyroid orbitopathy: Review of the literature].
    Bellot L; Graber M; Laurent C; Mouriaux F
    J Fr Ophtalmol; 2021 Oct; 44(8):1256-1261. PubMed ID: 34303550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual evoked potentials in patients with Graves' ophthalmopathy complicated by ocular hypertension and suspect glaucoma or dysthyroid optic neuropathy.
    Ambrosio G; Ferrara G; Vitale R; De Marco R
    Doc Ophthalmol; 2003 Mar; 106(2):99-104. PubMed ID: 12678273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No light perception vision from compressive thyroid orbitopathy.
    Hornbeak DM; Tamhankar MA; Eckstein LA
    Orbit; 2014 Feb; 33(1):72-4. PubMed ID: 24206015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysthyroid optic neuropathy: evaluation and management.
    Dolman PJ
    J Endocrinol Invest; 2021 Mar; 44(3):421-429. PubMed ID: 32729049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual field and orbital computed tomography correlation in dysthyroid optic neuropathy due to thyroid eye disease.
    Starks VS; Reinshagen KL; Lee NG; Freitag SK
    Orbit; 2020 Apr; 39(2):77-83. PubMed ID: 31057005
    [No Abstract]   [Full Text] [Related]  

  • 7. Visual function-specific perimetry for indirect comparison of different ganglion cell populations in glaucoma.
    Sample PA; Bosworth CF; Blumenthal EZ; Girkin C; Weinreb RN
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1783-90. PubMed ID: 10845599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optic neuropathy and diplopia from thyroid eye disease: update on pathophysiology and treatment.
    Johnson BT; Jameyfield E; Aakalu VK
    Curr Opin Neurol; 2021 Feb; 34(1):116-121. PubMed ID: 33278144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of multifocal visual evoked potentials in patients with Graves' orbitopathy and subclinical optic nerve involvement.
    Pérez-Rico C; Rodríguez-González N; Arévalo-Serrano J; Blanco R
    Doc Ophthalmol; 2012 Aug; 125(1):11-9. PubMed ID: 22581376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective endoscopic decompression of the orbital apex for dysthyroid optic neuropathy.
    Chu EA; Miller NR; Lane AP
    Laryngoscope; 2009 Jun; 119(6):1236-40. PubMed ID: 19418538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measuring contrast sensitivity in patients with Graves' ophthalmopathy complicated by ocular hypertension and suspect glaucoma or dysthyroid optic neuropathy.
    De Marco R; Ambrosio G; Ferrara G
    Doc Ophthalmol; 2000 Sep; 101(2):165-77. PubMed ID: 11200548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral optic nerve edema presenting as initial manifestation of thyroid eye disease.
    Wilson ME; Kim C; Carrasco J
    Orbit; 2016 Oct; 35(5):288-91. PubMed ID: 27486810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predominant Contribution of Superior Rectus-Levator Complex Enlargement to Optic Neuropathy and Inferior Visual Field Defects in Thyroid Eye Disease.
    Oropesa S; Dunbar KE; Godfrey KJ; Callahan AB; Campbell AA; Kazim M
    Ophthalmic Plast Reconstr Surg; 2019; 35(3):262-265. PubMed ID: 30124604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse glaucomatous structural and functional damage in the hemifield without significant pattern loss.
    Grewal DS; Sehi M; Greenfield DS
    Arch Ophthalmol; 2009 Nov; 127(11):1442-8. PubMed ID: 19901209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey.
    McKeag D; Lane C; Lazarus JH; Baldeschi L; Boboridis K; Dickinson AJ; Hullo AI; Kahaly G; Krassas G; Marcocci C; Marinò M; Mourits MP; Nardi M; Neoh C; Orgiazzi J; Perros P; Pinchera A; Pitz S; Prummel MF; Sartini MS; Wiersinga WM;
    Br J Ophthalmol; 2007 Apr; 91(4):455-8. PubMed ID: 17035276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-Related Changes in the Clinical Phenotype of Compressive Optic Neuropathy in Thyroid Eye Disease.
    Campbell AA; Nanda T; Oropesa S; Kazim M
    Ophthalmic Plast Reconstr Surg; 2019; 35(3):238-242. PubMed ID: 30234838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination Model of Thyrotrophin Receptor Antibody and Volumetric Orbital Apex Crowding Index as an Indicator of Dysthyroid Optic Neuropathy.
    Deng Z; Chen L; Tan J; Wang S; Liu D; Wang J; Jiang C; Yang J; Xu B
    Dis Markers; 2021; 2021():9964232. PubMed ID: 34113406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of retinal nerve fiber layer with optic nerve tracking optical coherence tomography in thyroid-associated orbitopathy.
    Forte R; Bonavolontà P; Vassallo P
    Ophthalmologica; 2010; 224(2):116-21. PubMed ID: 19729984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcaruncular orbital decompression: an alternate procedure for Graves ophthalmopathy with compressive optic neuropathy.
    Liao SL; Chang TC; Lin LL
    Am J Ophthalmol; 2006 May; 141(5):810-818. PubMed ID: 16527228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Ocular Hypertension and Glaucoma as Well as Associated Factors in Graves' Orbitopathy.
    Kim JW; Ko J; Woo YJ; Bae HW; Yoon JS
    J Glaucoma; 2018 May; 27(5):464-469. PubMed ID: 29557835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.